INTRODUCTION
aa mature peptide and composed of four repeated domains, each of which possesses distinct functions in its own synthesis and hemostasis [1] . Many genetic defects were identified recently and vast amount is enlisted in database dedicated to this bleeding disorder (http://mmg2.im.med. umich.edu) [2] . Most of them were identified in type 2 VWD and their association with each subtype of type 2 Background : We intended to find the mutations of von Willebrand factor (VWF) gene as the most important contributing factor of von Willebrand disease (VWD) in Korean patients.
Methods : In 40 known vWD patients mutations of vWF gene were sought by direct sequencing of PCR products targeting exons 18, 19, 20, 26, 28 and 52 frequently implicated as the locations of mutation. For factors other than VWF gene contributing to VWD phenotype, we tested ABO blood group and measured ADAMTS13 activity in VWD patients.
Results : Twenty-seven cases (67.5%) were type 1 vWD, 3 cases (7.5%) type 3, and 5 cases (12.5 %) type 2A. Three cases were type 2A or 2B (7.5%) and 2 cases were suspected to be type 2N (5.0 %). Among them six candidate missense mutations were found: V1279I, R1306W, R1308C, and V1316M were previously reported in type 2B and type 1 vWD, and C858W and T1477I were novel findings. All patients were heterozygotes. Blood group O was overly represented in VWD patients, while ADAMTS13 activity of the patients was not significantly different from that of normal control.
Conclusions : Mutation of VWF gene detected by genetic studies can significantly improve the diagnostic accuracy, especially in subtype assignment of VWD. Two novel mutations, C858W and T1477I associated with VWD were found and expected to contribute to the elucidation of its pathophysiology. (Korean J Lab Med 2007; 27:169-76 )
VWD is so specific as to endow the genetic study with diagnostic value. Furthermore the location of the mutations in each domain and corresponding derangement of the specific function of the domain is so well correlated that speculation of pathogenic mechanism of individual cases is not difficult in the majority of cases. On the contrary, genetic studies in type 1 VWD were always completed with low yield of mutation detection and a large part of its pathogenesis still remains uncovered [3] [4] [5] [6] [7] [8] . Significant overlap of VWF level from type 1 VWD patients and general population obscures clear distinction between VWD and normal phenotype [9] . This may explain the mysterious genetic aspect of type 1 VWD to some extent.
In Korea, despite the widespread appreciation of high prevalence of VWD, there has rarely been an attempt of genetic study of this disease. Only one case of VWD with novel candidate mutation of VWF gene has been reported till now [10] . We supposed that overall the mutation associated with VWD in Korea would not be greatly different from those enlisted in database collected worldwide, although there may be an occasional novelty. So, we screened the mutation of VWF gene in 40 patients with known VWD by PCR and direct sequencing method.
Additionally, to evaluate ABO blood group and ADA-MTS13, VWF cleaving plasma metalloproteinase as the contributing factors other than VWF gene in the pathogenesis of VWD, we tested ABO blood group and measured ADAMTS13 activity in VWD patients.
MATERIALS AND METHODS

Patients
Forty patients were included who were previously diagnosed with VWD in our and other institutions and referred then for related clinical tests to the department of laboratory medicine of our institution. At the time of the visit, whole blood collected in EDTA tube were obtained, aliquoted, and frozen at -80℃ until the genetic studies were done. Twenty seven (67.5%) of them were previously classified as type 1 VWD, 5 (12.5%) as type 2A, 3 as type 2A or 2B (7.5%; absence of large multimers without the result of ristocetin induced platelet aggregation test), and 3 (7.5%) as type 3 according to the findings from VWF multimer study (Table 1) . Two of them were suspected to have VWD type 2N (decreased factor VIII: C with normal VWF:Ag and VWF activity in female patient or family member). Specimens for family study were available in five of them, in one of which was found a highly suspected candidate mutation of VWF gene associated with VWD.
Measurement of VWF:Ag and VWF activity
We retested the VWF:Ag and VWF activity for eve- 
Mutation screening
The genomic DNA was extracted from EDTA whole blood after thawing using QIAamp DNA blood Mini kit 
RESULTS
Mutation screening results
Forty patients with known von Willebrand disease were screened for mutation of von Willebrand factor gene. Overall, 6 nucleotide substitutions with consequent amino acid substitutions were found in type 1 and type 2 VWD patients. Small to large deletions or insertions known to be associated with type 1 or type 3 VWD were not found.
Maybe PCR direct sequencing method we relied on was not appropriate for the detection of gross deletion or insertion occasionally associated with type 3 VWD. The results of screening are summarized in Table 2 with other laboratory data. All the repeated measurements showed almost the same results as tested when they were diagnosed.
Three of the 6 variations correspond to R1306W (3916 C>T), R1308C (3922 C>T) and V1316M (3946 G>A)
were located in domain A1 and all previously reported in association with type 2B VWD [13] [14] [15] [16] [17] [18] . Another was V1-279I (3835 G>A) reported in type 1 VWD [3] . All the nucleic acid substitutions in our study were found in heterozygous state. Association of each of these mutations with VWD subtypes in the literature was reaffirmed in our cases. In these cases the association of each mutation with VWD seems clear, although thorough family studies were not available due to incompliance or follow up loss. Table 2 . Laboratory data of the patients for whom candidate implicated mutations of VWF gene were found and past reports of each mutation 477I substitution were not found. A family study including the parents and sister was done for the patient with C858W substitution. Factor VIII:C activity of the patient was markedly decreased to 4%. The patient' s father also carried the same nucleotide substitution and his VWF:Ag and VWF activity were 21% and 8%, respectively, (35% and 22% for the patient), while those of his mother and sister who did not carry the substitution were 39%, 42%
C858W and T1477I found in two unrelated VWD patients
and 21%, 33%, respectively (Fig. 1A) . His family members included in this study had no noticeable past medical histories and did not complain of bleeding tendency.
Amino acid sequences of VWF from other species (Macaca mulatta, Sus scrofa, Canis familiaris, Mus musculus, Rattus norvegicus) were aligned with that of human for comparison. Cysteine at the 858th amino acid of VWF is well conserved throughout the species while neighboring amino acids showed some degree of interspecies variation (Fig. 1B) . This implies the importance of Cys858 for proper function of VWF, although the exact role of this residue cannot be unraveled to the structure level at this point.
T1477I is also strictly conserved and expected to be essential for proper function or synthesis of VWF (Fig. 1C ).
Factors other than VWF gene
Because mutation of VWF gene was found in only a small number of patients from a substantial size of patient group studied, we suspected that certain factors other than VWF itself has affected VWF activity. First, we reexamined the sequencing data for the presence of polymorphism Y1584C, which was recently reported to be prevalent in type 1 VWD implicating the susceptibility to AD-AMTS13 as an important factor influencing the development of VWD [19, 20] . But there was not a case with C1584 allele among the forty patients. We examined the effect of blood group, especially blood group O, which is known to be associated with low VWF level [9, 21] . Among the VWD patients who were blood typed, the prevalence of blood group O was significantly higher than it is known in general population (67% vs. 28%) [22] . This implies that along with other unknown factors, increased clearance of VWF in blood group O can reduce its level to the extent of VWD [21] . Next we also tested another factor related to VWF clearance, ADAMTS13. We measured ADAMTS13 activity with recently described fluorogenic synthetic substance [12] . ADAMTS13 activity in VWD patients was not significantly different from that measured in normal healthy individuals (P=0.238; Fig. 2 ).
Nor conld there be observed an apparent correlation between ADAMTS13 activity and VWF activity in plasma (data not presented). Confirmation with additional studies including factor VIII binding assay not included in this study and in vitro expression study should be followed and would be of help in elucidating the association with functional aberration.
ADAMTS13 (%)
Interestingly the patient' s family members who did not carry the C858W showed slightly decreased VWF:Ag levels. But VWF:Ag of these levels is known to be uncommonly associated with bleeding symptom and shows low heritability [27, 28] . ations [5] . Another is in close proximity to those cysteine residues (T1156M) [7] . The other two amino acid substitutions V1229G and N1231T were reported in type 1
VWD showing apparent autosomal recessive pattern of inheritance [6] . In vitro expression study has been done in few cases and the exact mechanism of aberrant synthesis is not yet fully described. Such an approach can be tried for the further investigation of our case with limited opportunity of thorough linkage study.
ADAMTS13 catalyzes the proteolysis of VWF between Y1584 and M1585 and consequently results in the clearance of large VWF multimers. Recently, it was reported that Y1584C substitution renders VWF susceptible to the action of ADAMTS13 and consequently results in increased clearance of VWF from plasma [19] . Actually the corresponding allele was found to be overly represented in type 1 VWD patients and their families by 25% and 27% respectively, compared with about 1% in general population [20] . The frequency of C1584 allele in east Asians is nearly zero (Entrez SNP database) and accordingly the substitution Y1584C was not found among VWD patients included in our study. Blood group O VWF is by far more susceptible to the cleavage by ADAMTS13 than other blood groups [29] . It can explain the well known pheno- 
